US Drug Recall Register

FDA Drug Recalls

1,523 recalls · Class III, newest first

Class III · Low risk Terminated

Azelastine HCl Ophthalmic Solution 0.05%

Reason Failed Impurities/Degradation Specifications:out-of-specification (OOS) results for Azelastine N-oxide

Akorn, Inc. NDC 17478-718-10 D-1168-2018
Class III · Low risk Terminated

Diltiazem HCl Extended-Release Capsules

Reason Failed Impurities/Degradation Specifications: Out of specification test results obtained during routine stability testing for related compound.

Mylan Pharmaceuticals Inc. NDC 0378-5220-05 D-1187-2018
Class III · Low risk Terminated

Diltiazem HCl Extended-Release Capsules

Reason Failed Impurities/Degradation Specifications: Out of specification test results obtained during routine stability testing for related compound.

Mylan Pharmaceuticals Inc. NDC 0378-5220-01 D-1186-2018
Class III · Low risk Terminated

Acne Treatment Pads

Reason Subpotent drug: The product active ingredient level not matching the exact levels indicated on the packaging label.

Huijing (Shanghai) Bio-tech Co., Ltd. NDC 71537-001-02 D-1076-2018
Class III · Low risk Terminated

Cicatricure

Reason Subpotent Drug: low out of specification assay results for the octocrylene and avobenzone ingredients.

Product Quest Manufacturing LLC D-0070-2019
Class III · Low risk Terminated

Well at Walgreens

Reason Subpotent Drug: low out of specification assay results for the octocrylene and avobenzone ingredients.

Product Quest Manufacturing LLC D-0069-2019
Class III · Low risk Terminated

Atorvastatin Calcium tablets

Reason Failed Impurities/Degradation Specifications - OOS was observed for ATV Cyclo FP Impurity and Total Degradation Impurities tested at the 18 month stability time point in Atorvastatin Calcium Tablets 40 mg 500 tablets.

Dr. Reddy's Laboratories, Inc. NDC 55111-123-05 D-1079-2018
Class III · Low risk Terminated

Levofloxacin Injection in 5% Dextrose

Reason Superpotent Drug: High out of specification results for levofloxacin resulting in increased concentration of solution.

Baxter Healthcare Corporation NDC 36000-048-24 D-1036-2018
Class III · Low risk Terminated

Levofloxacin Injection in 5% Dextrose

Reason Superpotent Drug: High out of specification results for levofloxacin resulting in increased concentration of solution.

Baxter Healthcare Corporation NDC 36000-047-24 D-1035-2018
Class III · Low risk Terminated

Levofloxacin Injection in 5% Dextrose

Reason Superpotent Drug: High out of specification results for levofloxacin resulting in increased concentration of solution.

Baxter Healthcare Corporation NDC 36000-046-24 D-1034-2018
Class III · Low risk Terminated

Moxifloxacin Ophthalmic Solution USP

Reason Failed Impurities/Degradation Specifications: An out-of-specification result in the related substance test during three month long-term stability study.

Lupin Pharmaceuticals Inc. NDC 68180-422-01 D-1050-2018
Class III · Low risk Terminated

Testosterone 200 mg Pellet

Reason Labeling: Incorrect or Missing Lot and/or Exp Date: Incorrect expiration date on label

Right Value Drug Stores, Inc. D-1047-2018
Class III · Low risk Terminated

Fluconazole Injection

Reason Superpotent Drug: lots out of specification for elevated sodium chloride and fluconazole assay.

Renaissance Lakewood, LLC D-1033-2018
Class III · Low risk Terminated

Fluconazole Injection

Reason Failed Stability Specifications: lot out of specification for elevated water vapor.

Renaissance Lakewood, LLC NDC 36000-002-10 D-1032-2018
Class III · Low risk Terminated

Fluconazole Injection

Reason Superpotent Drug and Failed Stability Specifications: lot out of specification for elevated sodium chloride and elevated water vapor.

Renaissance Lakewood, LLC NDC 36000-003-06 D-1031-2018
Class III · Low risk Terminated

Diazepam Rectal Gel

Reason Labeling: Incorrect or Missing Lot and/or Exp Date: Product distributed without a lot number or expiration date on the outer carton.

Valeant Pharmaceuticals North America LLC NDC 68682-650-20 D-1041-2018
Class III · Low risk Terminated

Enalapril Maleate

Reason Out-of-specification results for the Enalapril Diketopiperazine degradation product during commercial stability.

Aidarex Pharmaceuticals LLC D-0992-2018
Class III · Low risk Terminated

Enalapril Maleate

Reason Out-of-specification results for the Enalapril Diketopiperazine degradation product during commercial stability.

Aidarex Pharmaceuticals LLC D-0991-2018
Class III · Low risk Terminated

Enalapril Maleate

Reason Out-of-specification results for the Enalapril Diketopiperazine degradation product during commercial stability.

Aidarex Pharmaceuticals LLC D-0990-2018
Class III · Low risk Terminated

Enalapril Maleate Tablets

Reason Failed Impurities/Degradation Specifications: Sub-recall because this repackaged product was recalled by the manufacturing firm, Wockhardt, due to out-of-specification results for the Enalapril DiKetopiperazine degradation product.

Major Pharmaceuticals NDC 0904-5502-61 D-0980-2018
Class III · Low risk Terminated

Enalapril Maleate Tablets

Reason Failed Impurities/Degradation Specifications: Sub-recall because this repackaged product was recalled by the manufacturing firm, Wockhardt, due to out-of-specification results for the Enalapril DiKetopiperazine degradation product.

Major Pharmaceuticals NDC 0904-5609-61 D-0979-2018
Class III · Low risk Terminated

Enalapril Maleate Tablets USP

Reason Failed Impurities/Degradation Specification; out-of-specification results for the Enalapril DKT degradant

American Health Packaging NDC 68084-390-01 D-0915-2018
Class III · Low risk Terminated

Enalapril Maleate Tablets USP

Reason Failed Impurities/Degradation Specifications

Wockhardt Limited D-0913-2018
Class III · Low risk Terminated

Enalapril Maleate Tablets USP

Reason Failed Impurities/Degradation Specifications

Wockhardt Limited D-0912-2018